fasudil has been researched along with Liver Diseases in 2 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Liver Diseases: Pathological processes of the LIVER.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Thorlacius, K | 1 |
Slotta, JE | 1 |
Laschke, MW | 1 |
Wang, Y | 1 |
Menger, MD | 1 |
Jeppsson, B | 1 |
Thorlacius, H | 1 |
Ikeda, H | 1 |
Kume, Y | 1 |
Tejima, K | 1 |
Tomiya, T | 1 |
Nishikawa, T | 1 |
Watanabe, N | 1 |
Ohtomo, N | 1 |
Arai, M | 1 |
Arai, C | 1 |
Omata, M | 1 |
Fujiwara, K | 1 |
Yatomi, Y | 1 |
2 other studies available for fasudil and Liver Diseases
Article | Year |
---|---|
Protective effect of fasudil, a Rho-kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Apoptosis; Cell Communication; Chemo | 2006 |
Rho-kinase inhibitor prevents hepatocyte damage in acute liver injury induced by carbon tetrachloride in rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Androstadienes; Animals; Apoptosis; Carbon Tetrachlor | 2007 |